Cancer Care Management During the COVID-19 Pandemic
- PMID: 33061705
- PMCID: PMC7520144
- DOI: 10.2147/RMHP.S261357
Cancer Care Management During the COVID-19 Pandemic
Abstract
New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing around the world. Currently, health care services are mainly focused on responding to and controlling the unique challenges of the coronavirus disease 2019 (COVID-19) pandemic. These changes, along with the higher susceptibility of patients with cancer to infections, have profound effects on other critical aspects of care and pose a serious challenge for the treatment of such patients. During the COVID-19 pandemic, it is important to provide strategies for managing the treatment of patients with cancer to limit COVID-19-associated risks at this difficult time. The present study set out to summarize the latest research on epidemiology, pathogenesis, and clinical features of COVID-19. We also address some of the current challenges associated with the management of patients with cancer during the COVID-19 pandemic and provide practical guidance to clinically deal with these challenges.
Keywords: SARS-CoV-2; cancer; coronavirus; health care; pandemic.
© 2020 Jafari et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
References
-
- World Health Organization Press Conference. The World Health Organization (WHO) has officially named the disease caused by the novel coronavirus as COVID-19. Available from: https://wwwwhoint/emergencies/diseases/novel-coronavirus-2019. Accessed February11, 2020.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
